249 related articles for article (PubMed ID: 19526307)
1. Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
Ochi S; Taniguchi K; Nagashima M
Mod Rheumatol; 2009; 19(4):443-6. PubMed ID: 19526307
[TBL] [Abstract][Full Text] [Related]
2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
Gupta R; Bhatia J; Gupta SK
Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
[TBL] [Abstract][Full Text] [Related]
4. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
[No Abstract] [Full Text] [Related]
5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide induced acute interstitial pneumonia.
Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
[TBL] [Abstract][Full Text] [Related]
8. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Lange U; Piegsa M; Müller-Ladner U; Strunk J
Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
10. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
11. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
Bingham SJ; Buch MH; Kerr MA; Emery P; Valadäo Barcelos AT
Arthritis Rheum; 2004 Dec; 50(12):4072-3. PubMed ID: 15593202
[No Abstract] [Full Text] [Related]
12. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
13. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.
Godinho F; Godfrin B; El Mahou S; Navaux F; Zabraniecki L; Cantagrel A
Clin Exp Rheumatol; 2004; 22(3):328-30. PubMed ID: 15144127
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF; Gabay C
Ann Rheum Dis; 2012 Mar; 71(3):374-7. PubMed ID: 21972242
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab.
Marchesoni A; Arreghini M; Panni B; Battafarano N; Uziel L
Rheumatology (Oxford); 2003 Jan; 42(1):193-4. PubMed ID: 12509641
[No Abstract] [Full Text] [Related]
16. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
Singer O; Gibofsky A
Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide-associated infections in rheumatoid arthritis.
Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
[TBL] [Abstract][Full Text] [Related]
20. [Leflunomide--the first specific disease-modifying drug against rheumatoid arthritis].
Ringertz B; Petersson I
Lakartidningen; 2001 Feb; 98(6):566-7. PubMed ID: 11475244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]